A Sense of Hope: Cyrano Therapeutics’ Mission to Restore Sense of Smell
The sense of smell is an essential part of daily life, influencing how we enjoy food, connect with others, and stay safe in our environments. For millions of people worldwide, losing this critical sense can be life-altering, impacting both physical and mental health. Cyrano Therapeutics is leading the FLAVOR clinical trial program evaluating CYR-064, its lead investigational therapy for persistent post-viral smell loss.
The Growing Need for Solutions
Even before the COVID-19 pandemic, olfactory dysfunction affected more than 15 million Americans. Since COVID-19, long COVID has added thousands of new cases of persistent post-viral hyposmia daily. Today, more than 60 million people across the U.S., Europe, and Japan suffer from persistent post-viral hyposmia — a condition with no FDA-approved drug therapy and limited treatment options..
CYR-064: Results from the Phase 2 FLAVOR Trial
Cyrano Therapeutics’ lead investigational therapy, CYR-064, is a patent-protected, intranasal soft-mist spray formulation of a broad-spectrum phosphodiesterase (PDE) inhibitor with a targeted delivery system designed to enhance olfactory neuron excitability.
CYR-064 has completed its Phase 2 FLAVOR trial — a randomized, double-blind, placebo-controlled study enrolling 151 patients with persistent hyposmia (lasting at least 6 months) across 14 clinical sites in the U.S. The trial met its primary safety endpoint, with no treatment-related serious adverse events, and demonstrated durable improvements in smell function across multiple prespecified secondary efficacy endpoints. Based on these results, Cyrano is advancing CYR-064 into Phase 3 development in the second half of 2026.
“This is the first randomized, controlled trial to show a pharmaceutical agent can safely
improve smell function in patients with persistent post-viral hyposmia,”
said Rick Geoffrion, President and CEO of Cyrano Therapeutics.
Mas Takashima, MD, FACS, Chairman of the Department of Otolaryngology – Head and Neck Surgery at Houston Methodist Hospital and Principal Investigator of the FLAVOR trial, will present detailed data from the study at the 72nd Annual Meeting of the American Rhinologic Society, October 15–17, 2026, in Los Angeles — leading the “Oral Presentations: Top 5 Clinical Science” track.
Why Restoring the Sense of Smell Matters
The loss of smell, especially post viral smell loss, impacts more than just sensory perception; it affects how people navigate their lives. From diminished enjoyment of meals to difficulty identifying dangers like gas leaks or spoiled food, the challenges are profound. Social interactions can also suffer, leading to feelings of isolation and depression.
Restoring the sense of smell is about more than physical recovery—it’s about reclaiming a fuller, safer, and more connected life. Cyrano Therapeutics understands this need and is committed to advancing solutions that address both the scientific and emotional dimensions of smell loss.
Cyrano’s Commitment to Olfactory Health
Beyond developing innovative treatments, Cyrano Therapeutics is dedicated to raising awareness about olfactory dysfunction and its widespread impacts. Through education, advocacy, and cutting-edge research, Cyrano is helping to prioritize olfactory health as an essential component of overall well-being.
Their efforts extend beyond their laboratory. By encouraging participation in the FLAVOR clinical trials and fostering collaboration across the medical community, Cyrano is working to create a future where restoring the sense of smell is not just a possibility but a reality for millions.
A Future of Hope & Healing for Restoring a Sense Smell
Cyrano Therapeutics represents a beacon of hope for individuals affected by smell loss. With its pioneering approach to restoring the sense of smell, the company is not only advancing science but also transforming lives.
For those seeking to make a difference, supporting Cyrano’s mission or joining its FLAVOR clinical trials by Cyrano, for restoring a sense of smell, is an opportunity to contribute to a brighter future—one where sufferers can now smell the world around them, and with it, a renewed appreciation for the all that entails. Learn More about restoring your sense of smell today.